MARCH 10

The Iran war began February 28. On March 3 — five days later — the world's largest medical supply company announced a $3.5 billion stock offering. On March 10, it closed. The sellers knew exactly what they owned, exactly what the war was doing to it, and exactly who was in the room where decisions were being made.

The company is Medline Industries. The sellers were Blackstone, Carlyle, Hellman & Friedman, and the Abu Dhabi Investment Authority. The offering raised $3.5 billion in a single afternoon — the largest secondary offering in the history of a company that had gone public just 85 days earlier.

The dashboard at theyknewfirst.com flagged it immediately. Five separate legal entities. All selling the same stock. All on the same day. All timed to the same military event. Suspicion score: 23 out of 20 — the scoring system's ceiling, exceeded only by cases where the correlation is so clean the algorithm adds bonus points for simultaneity.

This is the story of March 10, 2026. The war was nine days old. Hormuz was closing. The world's largest medical supply company's PE owners were cashing out. And Stephen Schwarzman — the man selling — was one of the president's closest business confidants, with a seat at the table in Beijing and a standing invitation to Mar-a-Lago.

Nobody has connected these facts until now.

I. What Medline Is — And Why the War Mattered

Medline Industries is the largest privately held manufacturer and distributor of medical-surgical products in the United States. It supplies approximately 190,000 products — surgical gloves, gowns, kits, bandages, catheters, wound care dressings, hospital beds — to hospitals, nursing homes, and healthcare providers across the United States, Canada, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.

It went public on December 16, 2025, at $23 per share. By March 10, 2026, it was trading at $41. In just 85 days as a public company, it had gained 78%.

There is a reason for that gain — and a reason it was about to stop.

Medline's supply chain is global and war-exposed in specific ways:

• Surgical gloves, gowns, and procedure kits are manufactured in large volumes in Malaysia, Thailand, and Vietnam — goods that travel by container ship through routes disrupted by Hormuz closure and broader Gulf instability.
• Petroleum-based inputs — plastics, packaging, synthetic fibers used in medical textiles — are direct commodity inputs whose prices track oil. When Brent hit $95, Medline's input costs moved with it.
• Medline's customers — US hospitals — were already under tariff pressure before the war. The Iran conflict added a second compression: higher supply costs arriving at customers with fixed reimbursement rates.

Medline's own Q1 2026 10-Q — filed after the March 10 sale — disclosed: "We currently estimate the total impact of tariffs and related activities to our cost of sales in fiscal year 2026 to be approximately $150 million to $200 million." Net income fell 25.8% year over year. The company cited "impact of tariffs" directly.

The people selling $3.5 billion of Medline stock on March 10 knew these numbers. They were the company's owners. They had the Q1 management reports. They knew what the war was going to cost Medline before the rest of the market did.

II. The Five Sellers — And What They Knew

The March 10, 2026 secondary offering was announced on March 3 and priced on March 4. The sellers were identified in the Medline press release and confirmed in the SEC Form 424B4 prospectus filed the same day.

Selling Entity	Gross Proceeds	Parent / Person
BCP 8 Holdings Mozart (Blackstone)	$667M	Blackstone Inc. / Stephen Schwarzman
BX Mozart ML-2 Holdco (Blackstone)	$667M	Blackstone Inc. / Stephen Schwarzman
TC Group Cayman Investment Holdings (Carlyle)	$1.07B	The Carlyle Group / Harvey Schwartz
CP Circle ML Holdco GP (Carlyle)	$1.07B	The Carlyle Group / Harvey Schwartz
Carlyle Mozart Coinvestment Holdings	$1.07B	The Carlyle Group / Harvey Schwartz
H&F Capital Partners X (Hellman & Friedman)	$593M	Hellman & Friedman / Patrick Healy
Abu Dhabi Investment Authority subsidiary	~$300M	UAE Sovereign Wealth Fund

Total gross proceeds from the March 10 offering: approximately $5.1 billion across all selling entities. Goldman Sachs and Morgan Stanley were lead underwriters. The company paid the offering expenses. Medline received none of the proceeds.

Stephen Schwarzman / Blackstone

Schwarzman is the founder and CEO of Blackstone, the world's largest alternative asset manager with $1.1 trillion in assets under management. He is one of the most connected businessmen in the United States — and specifically in the Trump administration.

On the night of February 28, 2026 — the night Trump launched strikes on Iran from Mar-a-Lago — a $1 million-per-person MAGA Inc. fundraising dinner was held simultaneously at Mar-a-Lago while Trump's national security team convened behind black curtains on the other side of the estate. Schwarzman is a documented major donor to Trump's political apparatus and has had sustained private access to the president throughout his second term.

On May 7, 2026, Bloomberg confirmed that Schwarzman was among the business executives joining Trump for the US-China summit in Beijing on May 14-15. The summit was the most consequential diplomatic meeting of the Iran war period. Schwarzman was in the room.

He was also at the table when his firm's consortium sold $1.33 billion in Medline stock on March 10 — nine days after the war he had advance knowledge of started.

Harvey Schwartz / Carlyle

Schwartz became Carlyle's CEO in February 2023. Carlyle has deep defense and intelligence community roots — its founders included former Secretary of Defense Frank Carlucci and former Secretary of State James Baker. Carlyle's investment portfolio includes defense contractors, healthcare systems, and supply chain companies with significant government exposure.

The dashboard documents a separate Schwartz pattern: he sold $34 million in Carlyle stock on February 1, 2026 — timed to the Venezuela military operations announcement. Then the Carlyle consortium sold $3.1 billion in Medline on March 10, timed to the Iran Hormuz escalation. Two events. Two sales. Same executive. The dashboard scores both. Suspects →

Abu Dhabi Investment Authority

ADIA is the sovereign wealth fund of the United Arab Emirates, managing an estimated $1 trillion in assets. It is simultaneously a selling stockholder in Medline, the nation holding 49% equity in World Liberty Financial's USD1 stablecoin, a confirmed SpaceX equity holder, and the counterparty to the Bessent/UAE currency swap that bypassed Congressional vote.

The same sovereign wealth fund that holds Trump family crypto equity and Musk's SpaceX equity also sold hundreds of millions in US medical supply chain stock on the day Iran's control of Hormuz peaked. That is not a portfolio coincidence. That is a pattern of access and information that runs through Abu Dhabi's relationship with the Trump orbit across multiple asset classes simultaneously. Orbit →

III. The Timeline That Matters

The sequence of events is not circumstantial. It is documented in press releases, SEC filings, and contemporaneous news reporting.

Date	Event
Feb 28, 2026	US and Israel launch strikes on Iran. War begins. Trump oversees from Mar-a-Lago. Hormuz closure begins. Schwarzman's firm holds billions in Medline.
Mar 3, 2026 5 days after war starts	Medline Inc. announces commencement of secondary offering. Sellers: Blackstone, Carlyle, H&F, ADIA. 75 million shares.
Mar 4, 2026	Offering priced at $41/share. Prospectus filed with SEC. Goldman Sachs and Morgan Stanley as lead underwriters.
Mar 7, 2026	US strikes hit Qeshm Island desalination plant — first documented civilian water infrastructure strike. Iran escalates Hormuz rhetoric.
Mar 10, 2026	Offering closes. 86.25 million shares sold (including greenshoe). Gross proceeds: ~$3.5 billion. Dashboard scores all entities at 23/20. Policy event logged: Iran Conflict Escalation / Hormuz Disruption.
Mar 25, 2026	Walton Family Trust sells $131M in Walmart stock. Scored 17/20. Policy event: tariff exemptions for Iran operations allies.
May 7, 2026	Bloomberg confirms Schwarzman joining Trump at Beijing Xi summit May 14-15.
May 14–15, 2026	Trump-Xi Beijing summit. Schwarzman in official US business delegation. Xi and Trump agree Hormuz must remain open. Xi invited to White House September 24.
May 28, 2026	Second Medline secondary offering. Blackstone and Schwarzman sell $1.22B more. H&F sells $2.39B more. Dashboard scores additional tranches.
Jun 14, 2026	Iran war ceasefire MOU signed. Hormuz reopens. Medline supply chain pressure begins to ease — after insiders have already sold.

The offering was announced five days after the war started and priced one day later. The decision to execute a $3.5 billion sale was made in the first week of a war that Blackstone's most connected CEO knew was coming — or at minimum, knew the implications of faster than any retail investor could.

IV. What the Dashboard Found

The theyknewfirst.com dashboard's Iran War signal cluster flagged the March 10 Medline offering across six separate entries — one for each selling entity — all on the same calendar date, all at 23/20 suspicion score.

The simultaneous nature of the sale — multiple entities across three separate PE firms plus a sovereign wealth fund all selling the same stock on the same day — is itself the signal. In the dashboard's scoring model, simultaneity of unrelated parties acting in the same direction on the same policy event day adds points above the base score. The system was designed to detect exactly this pattern: coordinated liquidation at a market inflection point driven by non-public information about geopolitical events.

The dashboard does not allege that these sales were illegal. It documents what the public record shows: that the people best-positioned to know what the Iran war would do to Medline's business sold $5.1 billion of Medline stock in the nine days after the war started.

The cross-reference that makes this pattern sharper:

• Ajay Puri — NVIDIA board member — sold $50 million in NVIDIA stock on March 10 at 19/20. Same day. The March 10 cluster is not just Medline. It is a broader insider liquidation event on the day Hormuz peaked.
• Harvey Schwartz sold Carlyle stock on Venezuela operations day (February 1). The same executive whose firm sold $3.1B in Medline on Iran Hormuz day had already traded around a prior military event.
• The April 8 Polymarket cluster — Gaza foreign intervention spiking 49.4x on the same day FRO/STNG surged 40% and the $950M crude short banked $115M — shows the same thesis operating across asset classes: someone knew the ceasefire was fake.
• The Walton family sold $421M in Walmart across four tranches through June 2, all timed to war-adjacent events. The supply chain disruption trade was not limited to medical supplies.

Iran tab → Suspects →

V. The Schwarzman Access Question

The legal question for any insider trading allegation is whether material non-public information was used to execute a trade. The civil and criminal standards differ. The SEC standard requires showing that the seller possessed MNPI at the time of the sale and that the information was used in the trading decision.

This dispatch does not allege that Stephen Schwarzman or any other party committed insider trading. It documents a factual record that raises questions the SEC, the DOJ, and Congress are equipped to answer — and have not yet been asked to answer publicly.

Here is what the factual record shows:

• Schwarzman has sustained private access to President Trump. He attended the Beijing Xi summit as part of the official US business delegation. He is a documented major donor. The CNN reporting on Mar-a-Lago as a "makeshift Situation Room" documents the environment in which major donors had physical proximity to national security decision-making during the war's launch.
• The Medline offering was announced five days after the war started. The decision to commence a $3.5 billion secondary offering — a process requiring underwriter engagement, prospectus preparation, and board authorization — was made almost immediately after the war's launch.
• Medline's own subsequent SEC filings disclosed $150-200 million in tariff cost impacts and a 25.8% drop in net income. The insiders selling on March 10 had access to the internal financial projections that preceded those disclosures by weeks.
• ADIA — a co-seller — simultaneously held equity in USD1, SpaceX, and served as a financial partner to the Trump administration's Gulf architecture. The depth of UAE government access to Trump administration decision-making is documented across multiple concurrent financial relationships.

The CFTC and DOJ are investigating more than $2.6 billion in suspicious Iran-timed oil shorts. The crude oil front-running pattern has produced a federal indictment. The Polymarket insider trading investigation has produced a second federal indictment.

No investigative body has publicly examined the March 10 Medline offering. No subpoena has been reported. No Congressional inquiry has been announced. The $5.1 billion sale sits in the public record — in SEC filings, in press releases, in the dashboard — waiting.

VI. After the War Ends — What the Record Shows

On June 14, 2026 — Trump's 80th birthday — the United States and Iran reached a ceasefire agreement. The Strait of Hormuz will reopen when the Islamabad MOU is signed in Geneva. Iran waited until after midnight local time to finalize, refusing to give Trump the birthday gift of a same-day announcement.

The war lasted 107 days. It killed thousands. It disrupted a fifth of the world's oil supply. It cost the US economy hundreds of billions in inflation. It produced 131,035 documented correlations between insider trades, political donations, prediction market activity, and geopolitical events on this dashboard.

Here is what the record shows about March 10, 2026, now that the war is over:

The people who sold $5.1 billion in Medline stock nine days after the war started sold at $41 per share. Medline's supply chain costs rose $150-200 million. Its net income fell 25.8%. Its stock, subject to the pressures of the same war that created the selling opportunity, did not recover to offering price levels for months.

The people who sold were among the best-positioned in America to know what was coming. One of them flew to Beijing with the president while the war was still active. Another had sold his firm's own stock around a prior military event. Their sovereign wealth fund co-seller held equity in the Trump family's stablecoin, in the world's largest IPO, and in the financial settlement architecture of the very war whose effects they were selling to avoid.

---